首页> 外文期刊>journal of biopharmaceutical statistics >ON THE TIMING OF A FUTILITY ANALYSIS IN CLINICAL TRIALS
【24h】

ON THE TIMING OF A FUTILITY ANALYSIS IN CLINICAL TRIALS

机译:ON THE TIMING OF A FUTILITY ANALYSIS IN CLINICAL TRIALS

获取原文
       

摘要

In recent years, many researchers have been interested in performing futility analyses at interim points during clinical trials in order to terminate futile trials. To implement such an analysis, the researcher must decide what percentage of the total number of patients must have completed the trial before the interim analysis is done. This percentage is usually between 20 and 80. We examined the relationship between the percentage chosen and the probability of stopping the trial, given a parameter value associated with the treatment effect. The results of this examination will help the researcher plan when to do a futility analysis.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号